Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Acco Brands | ACCO | 24. dec 2024 | 5.27 | -0.38 |
Accolade | ACCD | 24. dec 2024 | 3.40 | -1.45 |
Accuray | ARAY | 24. dec 2024 | 1.94 | +3.74 |
Acelyrin | SLRN | 24. dec 2024 | 3.17 | -0.31 |
Achieve Life Sciences | ACHV | 24. dec 2024 | 3.79 | +0.26 |
Achilles Therapeutics ADR | ACHL | 24. dec 2024 | 1.14 | +16.18 |
ACI Worldwide | ACIW | 24. dec 2024 | 52.89 | +1.50 |
Aclarion | ACON | 24. dec 2024 | 0.13 | +1.11 |
Aclaris Therapeutics | ACRS | 24. dec 2024 | 2.90 | +0.35 |
ACM Research A | ACMR | 24. dec 2024 | 15.38 | +0.59 |
Acme United | ACU | 24. dec 2024 | 36.95 | -0.11 |
ACNB | ACNB | 24. dec 2024 | 40.77 | -1.62 |
ACRES Commercial Realty | ACR | 24. dec 2024 | 15.80 | +2.20 |
ACRES Commercial Realty C Pref | ACR-C | 24. dec 2024 | 25.15 | +0.08 |
ACRES Commercial Realty D Pref | ACR-D | 24. dec 2024 | 22.98 | +0.79 |
Acrivon Therapeutics | ACRV | 24. dec 2024 | 6.23 | -2.04 |
Actelis Networks | ASNS | 24. dec 2024 | 1.15 | -1.71 |
Actinium Pharmaceuticals | ATNM | 24. dec 2024 | 1.22 | -1.61 |
Active Bear ETF | HDGE | 24. dec 2024 | 16.13 | -0.49 |
Active U.S. Real Estate Powershares | PSR | 24. dec 2024 | 90.65 | +0.73 |
Actuate Therapeutics | ACTU | 24. dec 2024 | 7.53 | +10.25 |
Acuity Brands | AYI | 24. dec 2024 | 303.16 | +0.27 |
Acumen Pharmaceuticals | ABOS | 24. dec 2024 | 1.79 | +1.13 |
Acurx Pharmaceuticals | ACXP | 24. dec 2024 | 0.88 | +6.90 |
Acushnet | GOLF | 24. dec 2024 | 70.74 | +0.41 |
ACV Auctions A | ACVA | 24. dec 2024 | 21.67 | +1.17 |
ACWI Ex-US Index MSCI Ishares | ACWX | 24. dec 2024 | 52.60 | +0.36 |
ACWI Index MSCI Ishares | ACWI | 24. dec 2024 | 119.85 | +0.84 |
Adagene ADR | ADAG | 24. dec 2024 | 1.94 | +3.19 |
Adagio Medical | ADGM | 24. dec 2024 | 0.97 | -10.96 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.